logo
Select company
Select metric
95.96%Cash to Assets Ratio
VS
Market
99
Sector
98
Industry
96
History
100
$ 2.65Close
$ 1.55 - $ 2.72 52-Week Range
Ticker Information

Ticker

ENTX

Company Name

ENTERA BIO LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTERA BIO LTD - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTX - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 19.67M$ 18.87M95.96%
3/31/2025$ 21.6M$ 20.57M95.25%
12/31/2024$ 9.39M$ 8.66M92.23%
9/30/2024$ 7.74M$ 6.92M89.33%
6/30/2024$ 10.04M$ 9.06M90.24%
3/31/2024$ 10.24M$ 9.19M89.75%
12/31/2023$ 11.77M$ 11.02M93.66%
9/30/2023$ 8.56M$ 7.58M88.56%
6/30/2023$ 10.45M$ 9.13M87.46%
3/31/2023$ 11.61M$ 10.69M92.12%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTERA BIO LTD's latest trailing twelve months (TTM) Cash to Assets stands at 80.5%.
  • Over the past 5 years, ENTERA BIO LTD's average Cash to Assets has been 90.84%.
  • The median Cash to Assets for ENTERA BIO LTD during this period was 91.32%
  • ENTERA BIO LTD reached its highest Cash to Assets over the past 5 years at 95.96%.
  • The lowest Cash to Assets recorded by ENTERA BIO LTD in the same timeframe 80.5%

ENTERA BIO LTD's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
INO : INOVIO PHARMACEUTICALS INC 35.68%MNOV : MEDICINOVA INC 68.76%APLT : APPLIED THERAPEUTICS INC 81.47%SER : SERINA THERAPEUTICS INC 67.57%RPTX : REPARE THERAPEUTICS INC 51.85%INMB : INMUNE BIO INC 88.56%ABP : ABPRO HOLDINGS INC 58.25%HCWB : HCW BIOLOGICS INC 8.44%COEP : COEPTIS THERAPEUTICS HOLDINGS INC 16.38%EXOZ : EXOZYMES INC 72.19%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ENTERA BIO LTD is calculated as follows: CashnEq [ $ 7.07M ] / Assets [ $ 8.78M ]
(=) Cash to Assets [ 80.5% ]

ENTX - Cash to Assets Ratio, Last 5 years

80.5%

Minimum

Sep 30, 2020

95.96%

Maximum

Jun 30, 2025

90.84%

Average

91.32%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%